Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis
Jean‐Yves Reginster(King Saud University), Olivier Bruyère(University of Liège), John А. Kanis(University of Sheffield), Marc C. Hochberg(University of Maryland, Baltimore), Jaime Branco(Hospital de Egas Moniz), Maria Luisa Brandi(Vita-Salute San Raffaele University), Pieter D’Hooghe(Qatar Orthopaedic and Sports Medicine Hospital), René Rizzoli(University Hospital of Geneva), Gabriel Herrero‐Beaumont(Hospital Universitario Fundación Jiménez Díaz), Cyrus Cooper(University Hospital Southampton NHS Foundation Trust), J.‐P. Pelletier(Université de Montréal), E. Maheu(Sorbonne Université), Jean Pierre Devogelaer(Cliniques Universitaires Saint-Luc), Éric Abadie(Ifremer)
Cited by 23
Related Papers
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
|Osteoporosis International|2012|2.9k
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
|Osteoporosis International|2018|1.8k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k